These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8507539)

  • 1. Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage.
    Bjermer L; Grönberg H; Roos G; Henriksson R
    Biotherapy; 1993; 6(1):1-7. PubMed ID: 8507539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions.
    Viallat JR; Boutin C; Rey F; Astoul P; Farisse P; Brandely M
    Cancer; 1993 Jun; 71(12):4067-71. PubMed ID: 8508372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The kinetics of IL-2 after pleural administration in the treatment of neoplastic pleurisy].
    Astoul P; Bertault-Peres P; Durand A; Boutin C
    Rev Mal Respir; 1994; 11(1):29-35. PubMed ID: 8128091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
    Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
    Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion.
    Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C
    Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
    Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K
    Surg Today; 1993; 23(12):1053-9. PubMed ID: 8118118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural administration of recombinant interleukin-2 in non-small cell lung cancer with neoplastic pleural effusion.
    Masotti A; Fumagalli L; Morandini GC
    Monaldi Arch Chest Dis; 1997 Jun; 52(3):225-8. PubMed ID: 9270246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.
    Astoul P; Viallat JR; Laurent JC; Brandely M; Boutin C
    Chest; 1993 Jan; 103(1):209-13. PubMed ID: 8417880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2.
    Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T
    Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postoperative intrapleural instillations of interleukin-2 in patients with malignant pleurisy due to lung cancer.
    Yasumoto K; Nagashima A; Nakahashi H; Ishida T; Sugimachi K; Nomoto K
    Biotherapy; 1993; 6(2):133-8. PubMed ID: 8398572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
    Goey SH; Eggermont AM; Punt CJ; Slingerland R; Gratama JW; Oosterom R; Oskam R; Bolhuis RL; Stoter G
    Br J Cancer; 1995 Nov; 72(5):1283-8. PubMed ID: 7577483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrapleural administration of recombinant interleukin-2 in a patient with pleural effusion due to non-Hodgkin's lymphoma].
    Kojiro N; Ishihara H; Ito M; Nishiki M; Yamashita K; Onoshi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):954-9. PubMed ID: 2615111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for Stewart-Treves syndrome. Usefulness of intrapleural administration of tumor-infiltrating lymphocytes against massive pleural effusion caused by metastatic angiosarcoma.
    Furue M; Yamada N; Takahashi T; Kikuchi K; Tsuchida T; Ishibashi Y; Kobori O; Ihara A; Kitayama J; Minami M
    J Am Acad Dermatol; 1994 May; 30(5 Pt 2):899-903. PubMed ID: 8169271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer.
    Ardizzoni A; Bonavia M; Viale M; Baldini E; Mereu C; Verna A; Ferrini S; Cinquegrana A; Molinari S; Mariani GL
    Cancer; 1994 Mar; 73(5):1353-60. PubMed ID: 8111701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
    Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
    Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
    Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
    Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites.
    Huang XE; Wei GL; Huo JG; Wang XN; Lu YY; Wu XY; Liu J; Xiang J; Feng JF
    Asian Pac J Cancer Prev; 2013; 14(4):2611-4. PubMed ID: 23725184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.
    Thatcher N; Taylor P; Carroll KB; Loriaux EM; Palmer P; Franks CR
    Cancer Treat Rev; 1989 Jun; 16 Suppl A():161-2. PubMed ID: 2788503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.